Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

Stimulating dopamine-producing brain cells wirelessly with gold nanoparticles has proven effective at treating mice with ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in ...

Mice were protected against lethal snake toxins for the first time, in a ‘breakthrough’ moment thanks to artificial ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

The US biotech aims to bring its antibody-based therapies to human trials later in the year and to develop new candidate ...

The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional antivenoms fail.

Different types of antibodies are produced by your immune system. These five antibodies help fight disease by detecting viruses, bacteria, and other pathogens (disease-causing microorganisms) and ...

The current way to produce antivenoms is antiquated. Experiments in mice suggest that an artificial intelligence approach could save time and money.